Baxter (NYSE:BAX) shares are down today on mixed second-quarter results, with the medtech giant reducing its full-year outlook amid supply chain challenges and inflationary pressures. BAX shares were down more than 10% to $59.66 apiece in morning trading today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was up […]
Baxter
Baxter’s Volara lung therapy system recall is Class I
The FDA issued a notice today labeling the recall of the Baxter (NYSE:BAX) Volara lung therapy system as Class I, the most serious kind. Earlier this month, Baxter announced that it issued an urgent medical device correction for its Volara system for oscillation and lung expansion (OLE) therapy. To date, there has been one complaint […]
Baxter warns of risks around Volara lung therapy at home
Baxter (NYSE:BAX) announced that it issued an urgent medical device correction for its Volara system for oscillation and lung expansion (OLE) therapy. The warning from Baxter for the Volara system — manufactured by Hillrom, which Baxter acquired for $12.5 billion last year — reinforces important safety information regarding a possible risk of the decrease in […]
Baxter expects sales growth momentum through 2025
Baxter (NYSE:BAX) today issued long-term financial guidance that projects growth over the next three years. Shares of BAX were up 1.5% at $74.98 per share in midday trading today in response to the news. Deerfield, Illinois-based Baxter expects sales growth between 4% and 5% on a compounded annual basis from 2022 through 2025, with free […]
Thanks, mom! Medtech leaders reflect on Mother’s Day
Everyone has a story about how they got into medtech, and it’s no surprise that many of those stories start with how we were raised. As Mother’s Day approaches, Medical Design & Outsourcing asked medtech leaders to share some thoughts about how their moms inspired their careers, the products they make and the companies they’ve built. We […]
Baxter posts Street-beating Q1 results, cites ‘positive momentum’ from Hillrom acquisition
Baxter (NYSE:BAX) this week posted first-quarter results that beat the overall consensus on Wall Street. The Deerfield, Illinois-based maker of products to kidney disease — and a host of other chronic and acute medical conditions — reported profits of $71 million, or 14¢ per share, on sales of $3.7 billion for the three months ended […]
Baxter-sponsored study supports use of hemodynamic monitoring to help predict outcomes
Baxter (NYSE:BAX) announced today that study findings supported stroke volume and cardiac monitoring for predicting patient outcomes. The Baxter-sponsored study found that monitoring stroke volume and cardiac output trends for patients with critical conditions may offer vital insight into cardiac function and aid in predicting patient outcomes, including mortality. Deerfield, Illinois-based Baxter’s study findings were […]
FDA clears Baxter’s continuous renal replacement therapy system
Baxter (NYSE:BAX) announced today that it received FDA 510(k) clearance for its ST Set in continuous renal replacement therapy (CRRT). Deerfield, Illinois-based Baxter designed the ST Set as a pre-connected, disposable, extracorporeal circuit that provides blood purification through a semipermeable membrane for use with the PrisMax or Prismaflex control units. The platform has been available […]
Baxter settles with the SEC for $18M
The U.S. Securities and Exchange Commission announced today that Baxter will pay an $18 million penalty over foreign exchange trading practices that misstated the company’s earnings. In its annual report out today, Baxter said that it agreed to cease and desist from future violations, though it did not admit or deny the findings in the […]
Baxter warns of alarm malfunction on some infusion pumps
Baxter (NYSE:BAX) announced today that it has issued an urgent safety communication regarding upstream occlusion alarms for certain infusion pumps. Deerfield, Illinois–based Baxter warned that incorrect administration set setup and/or the incomplete resolution of upstream occlusion alarms may result in reduced delivery or non-delivery of medication. The problem might occur without the users receiving alerts […]
Baxter profits up 42% in Q4
Baxter (NYSE:BAX) today posted fourth-quarter results that beat the overall consensus on Wall Street. The Deerfield, Illinois-based company reported profits of $242 million, or 47¢ per share, on sales of $3.5 billion for the three months ended Dec. 31, 2021, for a bottom-line gain of 41.5% on sales growth of 10.5% compared with Q4 2020. Adjusted […]
